Mechanisms involved in the rapid, severe progression of fibrosis in the lung tissues of COVID-19 patients, a potentially fatal complication of the virus that damages and scars the lungs, have been ...

Chinese scientists have developed a novel nanotherapy known as biomimetic extracellular vesicle spherical nucleic acids (BEV-SNAs), which has shown efficacy in treating idiopathic pulmonary fibrosis ...

During the 1990s, medicinal chemist Anders Hallberg was working in his lab at the Department of Medicinal Chemistry. He was exploring a hormonal system in the body that regulates blood pressure, among ...

In honor of World Interstitial Lung Disease Day, the American Lung Association is launching a national campaign to raise awareness of progressive pulmonary fibrosis (PPF), which occurs when lung ...

Pulmonary fibrosis (PF) is a fatal lung disease characterized by excessive deposition of extracellular matrix proteins in the lung interstitium due to excessive fibroblast activation, which leads to ...

Six separate ageing clocks, run on the same 43 patients, all pointed in the same direction: younger predicted biological age ...

SAN FRANCISCO, April 03, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the completion of patient enrollment for ZEPHYRUS-2, a Phase 3 clinical study of pamrevlumab in patients ...

GRI Bio (GRI) said Thursday that the US Food and Drug Administration has granted Orphan Drug Designation (ODD) to GRI-0621 to treat Idiopathic Pulmonary Fibrosis. The designation is granted to ...